Release Date: 07/03/17 18:22 Summary: Appendix 3Y-Change in Directors Interest Price Sensitive: No Download Document Not available as of the moment. Download
RBL Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial